# Pharmacokinetic/Pharmacodynamic Study of Udenafil in Adolescents

> **NCT02201342** · PHASE1,PHASE2 · COMPLETED · sponsor: **Mezzion Pharma Co. Ltd** · enrollment: 36 (actual)

## Conditions studied

- Single Ventricle Heart Disease After Fontan Surgery

## Interventions

- **DRUG:** Udenafil

## Key facts

- **NCT ID:** NCT02201342
- **Lead sponsor:** Mezzion Pharma Co. Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-05-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02201342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02201342, "Pharmacokinetic/Pharmacodynamic Study of Udenafil in Adolescents". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02201342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*